|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL.: (2006.01) |
C07K 16/18 C07K 17/00 G01N 33/53 A61K 39/395 A61P 35/00 A61P 29/00 |
| (11) | Number of the document | 5416 |
| (13) | Kind of document | B |
| (21) | Application number | 2005 099 |
| (22) | Date of filing the application | 2005-11-08 |
| (41) | Date of publication of the application | 2006-11-27 |
| (45) | Date of publication of patent | 2007-04-25 |
| (86) | Number | PCT/US2003/026232 |
| Date | 2003-08-19 |
| (87) | Number | WO2004016769 |
| Date | 2004-02-26 |
| (30) | Number | Date | Country code |
| 60/404,802 | 2002-08-19 | US |
| (71) |
Abgenix, Inc.,
6701 Kaiser Drive, Fremont, CA 94555,
US
|
| (72) |
Jean M. GUDAS, US
Mary HAAK-FRENDSCHO, US Orit FOORD, US Meina L. LIANG, UA Kiran AHLUWALIA, US Sunil BHAKTA, US |
| (73) |
Abgenix, Inc.,
6701 Kaiser Drive, Fremont, CA 94555,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | ANTIBODIES DIRECTED TO MONOCLONAL CHEMO-ATRACTANT PROTEIN-1 (MCP-1) AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2009-07-21 | 7 | 560.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2010-08-19 |